BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36098470)

  • 21. The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.
    Bidstrup TB; Damkier P; Olsen AK; Ekblom M; Karlsson A; Brøsen K
    Br J Clin Pharmacol; 2006 Jan; 61(1):49-57. PubMed ID: 16390351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
    Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
    Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
    Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
    Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers.
    Kale P
    Front Pharmacol; 2014; 5():98. PubMed ID: 24847268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
    Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
    Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
    Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
    Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of a fixed-dose repaglinide/metformin combination tablet and equivalent doses of repaglinide and metformin tablets
.
    Cho HY; Ngo L; Kim SK; Choi Y; Lee YB
    Int J Clin Pharmacol Ther; 2018 Jun; 56(6):292-300. PubMed ID: 29648532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.
    Hsyu PH; Singh A; Giargiari TD; Dunn JA; Ascher JA; Johnston JA
    J Clin Pharmacol; 1997 Aug; 37(8):737-43. PubMed ID: 9378846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pitavastatin in different SLCO1B1 backgrounds on repaglinide pharmacokinetics and pharmacodynamics in healthy Chinese males.
    Zhu J; Song M; Tan HY; Huang LH; Huang ZJ; Liu C; Fu ZM; Huang YY; Tan ZR; Chen XP; Yuan H; Yang GP
    Pak J Pharm Sci; 2013 May; 26(3):577-84. PubMed ID: 23625433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects.
    Keyvanjah K; DiPrimeo D; Li A; Obaidi M; Swearingen D; Wong A
    Br J Clin Pharmacol; 2017 Mar; 83(3):554-561. PubMed ID: 27628584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of sodium ferulate on the pharmacokinetics of bupropion and its active metabolite in healthy men.
    Gao LC; Huang X; Tan ZR; Fan L; Zhou HH
    Eur Rev Med Pharmacol Sci; 2012 Sep; 16(9):1192-6. PubMed ID: 23047502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide.
    Niemi M; Leathart JB; Neuvonen M; Backman JT; Daly AK; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Oct; 74(4):380-7. PubMed ID: 14534525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic effects of proton pump inhibitors on the novel PARP inhibitor fluzoparib: a single-arm, fixed-sequence trial in male healthy volunteers.
    Li L; Xiang YX; Yang GP; Zhang XF; Yang XY; Yang S; Huang J
    Invest New Drugs; 2021 Jun; 39(3):796-802. PubMed ID: 33420642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
    Marraffino A; Sikes CR; Laage T; Volosov A; Hart A; Engelking D
    J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):15-20. PubMed ID: 31295008
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; La S; Kim HJ; Cho S; Yoon YR; Yang DH; Lee HW
    Drug Des Devel Ther; 2018; 12():545-553. PubMed ID: 29559771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
    Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
    Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single dose bioequivalence study of two brands of olanzapine 10 mg tablets in Iranian healthy volunteers.
    Zakeri-Milani P; Islambulchilar Z; Ghanbarzadeh S; Valizadeh H
    Drug Res (Stuttg); 2013 Jul; 63(7):346-50. PubMed ID: 23605469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
    Kharasch ED; Mitchell D; Coles R
    J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects.
    Yamazaki T; Desai A; Goldwater R; Han D; Howieson C; Akhtar S; Kowalski D; Lademacher C; Pearlman H; Rammelsberg D; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):54-65. PubMed ID: 27273149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2C8 activity recovers within 96 hours after gemfibrozil dosing: estimation of CYP2C8 half-life using repaglinide as an in vivo probe.
    Backman JT; Honkalammi J; Neuvonen M; Kurkinen KJ; Tornio A; Niemi M; Neuvonen PJ
    Drug Metab Dispos; 2009 Dec; 37(12):2359-66. PubMed ID: 19773535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.